By Tarena Lofton Susanna Harris was sitting in her lab class for her graduate program at the University of North Carolina at Chapel Hill when she received an email that told her she had failed what she describes as “the most important exam in grad school,” the doctoral qualifying exam.
Suresh Vedantham, MD, past president of the Society of Interventional Radiology, will receive the 2019 Venous Educator, Innovator, and National Statesman Award (VEIN AWARD) during VIVA and The VEINS2019 conference Nov. 4-7 at the Wynn Las Vegas. Dr. Vedantham is a professor of Radiology & Surgery at the Mallinckrodt Institute of Radiology at the
Medtronic plc released new data on endovascular repair of abdominal aortic aneurysm (AAA) patients with the Endurant II/IIs stent graft system in combination with Heli-FX EndoAnchor implants and for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR). The data, which was presented at the Charing Cross
As a hedge against the 2023 expiration of its U.S. patents that protect its blockbuster drug, Humira, AbbVie Inc. will acquire Dublin, Ireland-based Allergan for $63 billion in cash and stock. Humira sales account for more than 60 percent of AbbVie’s revenue, but biosimilar drugs approved in Europe
By Judith Graham A common myth about aging is that older adults are burdened by illness and feel lousy much of the time. In fact, the opposite is usually true. Most seniors report feeling distinctly positive about their health. Consider data from the 2017 National Health Interview Survey (the most
The U.S Food and Drug Administration has approved Boston Scientific’s VICI Venous Stent System for the treatment of iliofemoral venous obstructive disease, which occurs when the flow of blood through the veins located deep in the pelvic region becomes blocked by a blood clot or compressed by anatomical anomalies.
VECLOSE EXTENSION STUDY: Five-year outcomes prove durability, safety, efficacy of VenaSeal Closure System
By Larry Storer Five-year results from the 2019 VeClose Extension Study of the Medtronic VenaSeal Closure System demonstrate that the treatment modality is consistent, durable and safe for permanently closing veins in patients with venous reflux disease. When compared with Medtronic Radiofrequency Ablation, VenaSeal continued to show “non-inferiority”
Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins. Also effective April 8, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All HCPs will now be able to purchase Asclera directly
By JoNel Aleccia After nearly 40 years as an internist, Portland, Oregon physician Ron Naito knew what the sky-high results of his blood test meant. And it wasn’t good. But when he turned to his doctors last summer to confirm the dire diagnosis — stage 4 pancreatic cancer —
By Harriet Blair Rowan Buprenorphine, a relative newcomer in the treatment of opioid addiction, is growing in popularity among California doctors as regulatory changes, physician training and other initiatives make the medication more widely accessible. The rate of Medi-Cal enrollees who received buprenorphine nearly quadrupled from the end of 2014 to